BACKGROUND: Existing tools for rapid cognitive assessment in HIV-positive individuals with mild cognitive deficits lack sensitivity or do not meet psychometric requirements for tracking changes in cognitive ability over time. METHODS: Seventy-five nondemented HIV-positive patients were evaluated with the Montreal Cognitive Assessment (MoCA), a brief battery of standardized neuropsychological tests, and computerized tasks evaluating frontal-executive function and processing speed. Rasch analyses were applied to the MoCA data set and subsequently to the full set of data from all tests. RESULTS: The MoCA was found to adequately measure cognitive ability as a single, global construct in this HIV-positive cohort, although it showed poorer precision for measuring patients of higher ability. Combining the additional tests with the MoCA resulted in a battery with better psychometric properties that also better targeted the range of abilities in this cohort. CONCLUSION: This application of modern test development techniques shows a path towards a quick, quantitative, global approach to cognitive assessment with promise both for initial detection and for longitudinal follow-up of cognitive impairment in patients with HIV infection.
BACKGROUND: Existing tools for rapid cognitive assessment in HIV-positive individuals with mild cognitive deficits lack sensitivity or do not meet psychometric requirements for tracking changes in cognitive ability over time. METHODS: Seventy-five nondemented HIV-positive patients were evaluated with the Montreal Cognitive Assessment (MoCA), a brief battery of standardized neuropsychological tests, and computerized tasks evaluating frontal-executive function and processing speed. Rasch analyses were applied to the MoCA data set and subsequently to the full set of data from all tests. RESULTS: The MoCA was found to adequately measure cognitive ability as a single, global construct in this HIV-positive cohort, although it showed poorer precision for measuring patients of higher ability. Combining the additional tests with the MoCA resulted in a battery with better psychometric properties that also better targeted the range of abilities in this cohort. CONCLUSION: This application of modern test development techniques shows a path towards a quick, quantitative, global approach to cognitive assessment with promise both for initial detection and for longitudinal follow-up of cognitive impairment in patients with HIV infection.
Authors: Edith V Sullivan; Ty Brumback; Susan F Tapert; Rosemary Fama; Devin Prouty; Sandra A Brown; Kevin Cummins; Wesley K Thompson; Ian M Colrain; Fiona C Baker; Michael D De Bellis; Stephen R Hooper; Duncan B Clark; Tammy Chung; Bonnie J Nagel; B Nolan Nichols; Torsten Rohlfing; Weiwei Chu; Kilian M Pohl; Adolf Pfefferbaum Journal: Neuropsychology Date: 2016-01-11 Impact factor: 3.295
Authors: David E Vance; Pariya L Fazeli; Linda Moneyham; Norman L Keltner; James L Raper Journal: J Assoc Nurses AIDS Care Date: 2013 Jan-Feb Impact factor: 1.354
Authors: Reuben N Robbins; Henry Brown; Andries Ehlers; John A Joska; Kevin G F Thomas; Rhonda Burgess; Desiree Byrd; Susan Morgello Journal: J Mob Technol Med Date: 2014-02-01
Authors: Mark A Espeland; Jeffrey A Katula; Julia Rushing; Arthur F Kramer; Janine M Jennings; Kaycee M Sink; Neelesh K Nadkarni; Kieran F Reid; Cynthia M Castro; Timothy Church; Diana R Kerwin; Jeff D Williamson; Richard A Marottoli; Scott Rushing; Michael Marsiske; Stephen R Rapp Journal: Int J Geriatr Psychiatry Date: 2013-04-16 Impact factor: 3.485
Authors: Reuben N Robbins; John A Joska; Kevin G F Thomas; Dan J Stein; Teboho Linda; Claude A Mellins; Robert H Remien Journal: Clin Neuropsychol Date: 2013-01-21 Impact factor: 3.535
Authors: Edgar Turner Overton; Tej D Azad; Neva Parker; Debra Demarco Shaw; Judy Frain; Teresa Spitz; Elizabeth Westerhaus; Robert Paul; David B Clifford; Beau M Ances Journal: J Neurovirol Date: 2013-01-24 Impact factor: 2.643